Hemay005: Clinical Trials

6 trials of Hemay005, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 active not recruiting, 1 not yet recruiting, 1 terminated. 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 26Completed 3, Active not recruiting 1, Not yet recruiting 1, Terminated 1

Follow Hemay005: new trials by email Literature Review of Hemay005 trials Research Report on Hemay005

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate the Biomarkers of Hemay005 in Adult Participants With Moderate to Severe COPD
Hemay005 tablets, Roflumilast Oral Tablet, Placebo tablet - COPD (Chronic Obstructive Pulmonary Disease)
Phase 2Not yet recruitingGanzhou Hemay Pharmaceutical Co., Ltd1202026-01-012026-01-02
A Study of Hemay005 in Adult With Atopic Dermatitis
Hemay005 - Hemay005, Atopic Dermatitis
Phase 2CompletedGanzhou Hemay Pharmaceutical Co., Ltd792022-11-242024-03-01
Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis
Hemay005 tablets, Hemay005 placebo tablets - Moderate to Severe Ulcerative Colitis
Phase 2Active not recruitingGanzhou Hemay Pharmaceutical Co., Ltd922022-11-082026-04-03
Phase II Study of Hemay005 in Patients With Active Ankylosing Spondylitis
Hemay005 - Active Ankylosing Spondylitis
Phase 2CompletedTianjin Hemay Pharmaceutical Co., Ltd902022-08-052024-01-11
A Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease
Hemay005, Placebo - Behçet Disease
Phase 2TerminatedTianjin Hemay Pharmaceutical Co., Ltd892020-11-302022-06-21
Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis
15mg Hemay005, Placebos - Psoriasis
Phase 2CompletedTianjin Hemay Pharmaceutical Co., Ltd2162019-05-302021-10-13

Conditions studied

Behcet Syndrome (1)  ·  Dermatitis, Atopic (1)  ·  Psoriasis (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Sponsors

Ganzhou Hemay Pharmaceutical Co., Ltd (3)  ·  Tianjin Hemay Pharmaceutical Co., Ltd (3)

Countries

China (6)

Top investigators

Min Zheng, Dr (1)  ·  Shutian Zhang, MD (1)  ·  Xiaofeng Zeng, M.D (1)

Results publications

PMID 41748391